[1]
Селюк, М.М., Козачок, М.М., Льовкін, І.М., Бесага, В.В., Лівінська, О.Г., Пономаренко, М.А. and Дударь, Л.М. 2018. Influence of molsidomine (Sidnofarma) on indices of central hemodynamics and tolerance disorders to physical activity in patients with stage II arterial hypertension. Family medicine. 3 (Aug. 2018), 67–74. DOI:https://doi.org/10.30841/2307-5112.3.2018.146572.